Dr Michelle Khoo

Dr. Michelle Khoo

About Dr. Michelle Khoo

One of the Best Cardiologists in Albuquerque

Dr. Khoo is a board certified Cardiologist and Clinical Cardiac Electrophysiologist. She attended medical school at Trinity College Dublin and completed her Internal Medicine residencies at Tufts University in Massachusetts. She then trained in Cardiovascular Diseases and Clinical Cardiac Electrophysiology at Vanderbilt University in Nashville, Tennessee. Thereafter, she was Assistant Professor of Medicine at University of Colorado before she moved to Albuquerque. Her interests are wellness and prevention of heart disease, sudden death prevention, as well as palliative care in advanced heart disease.

Dr Khoo has been recognized as a top cardiologist in Sequential and is honored to have been chosen ‘Best Doctor’ in Cardiology by Albuquerque the Magazine in 2012 thru 2014. She placed second in voting for this category in 2015.

Her hobbies include meeting new people, kung fu and qi gong practice, travel and food.

Degrees and Education

Undergraduate School:

A Levels, Newman College, Dublin, Ireland

B.A., Trinity College, University of Dublin, Ireland

M.B. (Bachelor in Medicine), B.Ch. (Bachelor in Surgery), B.A.O. (Bachelor in Obstetrics), Trinity College, University of Dublin, Ireland

Internships

General Medicine – St. James’s Hospital, Dublin, Ireland

Internal Medicine – Baystate Medical Center, Western Campus of Tufts University, Massachusetts

Residency

Internal Medicine – St. James’s Hospital, Dublin, Ireland

Internal Medicine – Baystate Medical Center, Western Campus of Tufts University, Massachusetts

Fellowships

Cardiology – Vanderbilt University Medical Center, Tennessee

Clinical Cardiac Electrophysiology – Vanderbilt University Medical Center, Tennessee

Special Interests

Cardiology, Cardiac Electrophysiology

American Board of Internal Medicine

American Board of Internal Medicine – Cardiovascular Disease

American Board of Internal Medicine – Clinical Cardiac Electrophysiology

AWARDS

  • “Best Doctor” in Cardiology – Albuquerque the Magazine 2012 -2015
  • 2012 Fellow (FHRS) – Heart Rhythm Society
  • 2008 Fellow (FACC) – American College of Cardiology
  • May 2006 Outstanding Publication Award for Young Electrophysiologists (Experimental Research) – Heart Rhythm Journal – Calmodulin kinase II activity is required for normal atrioventricular nodal conduction. Khoo MSC et al, Heart Rhythm 2005;2(6):634-40
  • June 2004 Best Consultant Award – Department of Emergency Medicine – Vanderbilt University Medical Center
  • July 2003 – June 2004 Chief Fellow – Division of Cardiovascular Medicine – Vanderbilt University Medical Center
  • May 2004 Cardiology Fellow Teaching Award – Department of Medicine, Vanderbilt University Medical Center
  • March 2004 Annual Cardiology Fellows Research Forum
  • July 2001 – June 2003 American Heart Association Postdoctoral Fellowship Award
  • November 2002 Annual Cardiology Fellows Forum of Excellence
  • June 2002 Sponsored Young Investigator – Glaxo Smithkline Research & Education Foundation for Cardiovascular Disease
  • May 2002 Cardiovascular Medicine Fellowship Research Prize Award – Department of Medicine, Vanderbilt University Medical Center
  • April 2002 Best Poster Prize – 20th Vanderbilt University Medical Center Research Forum
  • March 2002 American College of Cardiology – Bristol-Myers Squibb Affiliate Travel Award
  • May 1991 Trinity College Foundation Scholarship
  • 1991 Wellcome Scholarship, Wellcome Trust – Institute of Molecular Medicine, University of Oxford, UK

PUBLICATIONS

Original Investigations

1. Weiss R, Malik R, Wish M, Dinerman J, Petrutiu S, Khoo MSC. VV optimization in cardiac resynchronization therapy non-responders: RESPONSE HF Trial results. Submitted

2. Bargas, RL, Coogan E, Lowery CM, Movasagghi B, Wink O, Peterson D, Lewkowiez L, Sauer WH, Salcedo EE, Khoo MSC. Optimal left ventricular lead placement using real-time overlay of 3D-echocardiographic dyssynchrony shell and rotational fluoroscopy improves CRT response and LV remodeling. Submitted

3. Sauer WH, Drexel T, Belardi D, Bargas R, Stees C, Schuller J, Lowery CM, Khoo MSC. QRS shortening after cardiac resynchronization therapy is associated with increased left ventricular ejection fraction in patients with non-ischemic cardiomyopathy. Submitted

4. Henry-Okafor Q, Cowan P, Wicks MN, Rice M, Husch DS, Khoo MSC. Effect of obesity on cardiovascular risk factors in African-american women. Biol Res Nurse 2011.

5. Stees C, Khoo, MSC, Lowery C, Sauer W. Ventricular tachycardia storm successfully treated with immunosuppression and catheter ablation in a patient with cardiac sarcoidosis. Journal Cardiovasc Electropys 2011;22(2):210-3

6. Henry-Okafor Q, Cowan P, Zhao DXM, Khoo MSC. Racial differences in cardiac risk profiles in women undergoing cardiac catheterization. American Journal for Nurse Practitioners 2009;13(4):49-54.

7. Khoo MSC, Grueter CE, Ni G, Eren M, Yang J, Zhang R, Bass MA, Lwin STS, Mendes LA, Vaughan DE, Colbran RJ, Anderson ME. Calmodulin Kinase determines cardiac dysfunction due to transgenic expression of green fluorescent protein. Journal of Molecular and Cellular Cardiology 2008;44:405-410 Epub 2007 Nov.

8. Khoo MSC, Li J, Yang, Y, Kannankeril P, Grueter CE, Oddis CV, Zhang R, Mendes L, Ni G, Madu E, Yang J, Bass M, Gomez RJ, Wadzinski BE, Olson EN, Colbran RJ, Anderson, ME. Death, cardiac dysfunction and arrhythmias due to up-regulation of calmodulin kinase II in calcineurin-induced cardiomyopathy. Circulation 2006;114:1352-1359.

9. Khoo MSC, Kannankeril PJ, Li J, Zhang R, Kupershmidt S, Zhang W, Atkinson JBA, Colbran RJ, Roden DM, Anderson ME. Calmodulin kinase II activity is required for normal atrioventricular nodal conduction. Heart Rhythm 2005;2(6):634-640.

10. Zhang R*, Khoo MSC*, Wu Y*, Yang Y*, Grueter CE, Ni G, Price EE, Thiel W, Guatimosim S, Song L, Madu EC, Shah A, Vishnivetskaya T, Atkinson JB, Gurevich VV, Salama G, Lederer WJ, Colbran RJ, Anderson ME. Calmodulin kinase II inhibition protects against structural heart disease: a novel approach for selectively targeting pathological responses to beta adrenergic receptor signaling. (* Denotes equal first authorship) Nature Medicine 2005;11(4):409-417 Epub 2005 Mar 27.

11. Rottman JN, Ni G, Khoo M, Wang Z, Anderson ME, Madu EC. Temporal changes in ventricular function assessed echocardiographically in conscious and anesthetized mice. J Am Soc Echocardiogr 2003, 16(11):1150-1157.

12. Khoo MSC, Braden G, Deaton D, Owen S, Germain M, O’Shea M, Mulhern J, Rousou JA, Flack JE, Engelman RM. Outcome and complications of intraoperative hemodialysis during cardiopulmonary bypass with potassium-rich cardioplegia. Am J Kidney Dis 2003;41:1247-1256.

13. Gbadebo TD, Trimble RW, Khoo MSC, Temple J, Roden DM, Anderson ME. The calmodulin inhibitor W-7 unmasks a novel ECG parameter that predicts initiation of torsade de pointes. Circulation 2002;105:770-774.

14. Gerstenfeld EP, Khoo M, Martin R, Cook JR, Lancey R, Rofino K, VanderSalm TJ, Mittleman RS. Effectiveness of bi-atrial pacing for reducing atrial fibrillation after coronary artery bypass graft surgery. J Interv Card Electrophysiol 2001;5(3):275-283.

15. Ruwende C, Khoo SC, Snow RW, Yates SNR, Kwiatkowski D, Gupta S, Warn P, Allsopp CEM, Gilbert SC, Peschu N, Newbold CI, Greenwood BM, Marsh K, Hill AVS. Natural selection of hemizygotes and heterozygotes for glucose-6-phosphate dehydrogenase deficiency in Africa by resistance to severe malaria. Nature 1995;376:246-249.

Reviews, Case Reports, Letters, Editorials

1.Khoo MSC, Mestroni L, Taylor MRG. Clinical Approach to Sudden Cardiac Death Syndromes: Dilated Cardiomyopathy. Ed. Brugada R. Springer London 2010.

2. Khoo MSC, Kelly P, Lindenfeld J. Cardiac Resynchronization Therapy in Class IV
Heart Failure Patients. Current Reports 2009;11:175-183.

3. Khoo MSC, Scholl F, Dignan R, Rottman JN. Migration and infection of a pace-sense lead from an abdominal defibrillator system. PACE 2002;25:1652-1655.

Peer-Reviewed Abstracts

1. Khoo MSC, Miller, K, Sauer WH, Olmsted R, Fedewa, M. LV lead position does not predict response to cardiac resynchronization therapy. Journal of Cardiac Failure 2010

2. Weiss R, Malik, R, Wish M, Dinerman J, Lee L, Petrutiu S, Khoo MSC. V-V Optimization in Cardiac Resynchronization Therapy Non-responders: RESPONSE-HF Trial Results. Heart Rhythm 2010

3. Lowery CM, Bargas RL, Stees CS, Schuller JL, Belardi DF, Aleong RG, Khoo MSC. Varosy PD, Sauer WH. Induction of Ventricular Fibrillation is not necessary for Successful Ablation in Patients with Structural Heart Disease and Severe Heart Failure. Heart Rhythm 2010

4. Schuller JL, Zipse MM, Bargas RL, Stees CS, Aleong RG, Khoo MSC, Lowery CM, Varosy PD, Gottschall B, Maier L, Rose C, Hamzeh N, Weinberger H, Sauer WH. Patients with Cardiac Sarcoidosis and a Primary Prevention Implantable Cardioverter Defibrillator Have a Higher Incidence of Ventricular Tachycardia Storm Compared to Patients with Non-Sarcoidosis Cardiomyopathies. Heart Rhythm 2010

5. Zipse MM, Schuller JL, Bargas RL, Stees CS, Aleong RG, Khoo MSC, Lowery CM, Varosy PD, Gottschall B, Maier L, Rose C, Hamzeh N, Weinberger H, Sauer WH. Signal Averaged Electrocardiography is a Useful Screening Tool for Cardiac Involvement of Sarcoidosis in Patients with a Narrow QRS Complex. Heart Rhythm 2010

6. Schuller JL, Zipse MM, Bargas RL, Stees CS, Aleong RG, Khoo MSC, Lowery CM, Varosy PD, Gottschall B, Maier L, Rose C, Hamzeh N, Weinberger H, Sauer WH. Patients with Cardiac Sarcoidosis and an Implanted Cardioverter-Defibrillator can have Late Reduction in Measured R-waves Requiring Lead Revision. Heart Rhythm 2010

7. Bargas RL, Stees CS, Schuller JL, Belardi DF, Aleong RG, Varosy PD, Khoo MSC, Sauer WH, Lowery CM. Typical Flutter in an Atypical Patient: Ablation of “Clockwise” Atrial Flutter in a Patient with Situs Inversus Totalis and Limited Venous Access. Heart Rhythm 2010

8. Stees C, Sauer WH, Lowery CM, Belardi D, Schuller J, Bargas R, Weinberger H, Quaife R, Khoo MSC. Successful treatment of sarcoid related ventricular tachycardia storm with immunosuppresion and catheter ablation. Journal of Cardiac Failure, 2009:15(6):S58-9

9. Miller K, Merliss A, Khoo M, Sauer W, Yamada G, Thohan V, Brown JR, Fedewa, MM. Cardiac resynchronization therapy responders have echo Doppler optimized AV intervals closest to nominal settings. Journal of Cardiac Failure, 2009:15(6):S115

10. Rhodes T, Oza A, Khoo MSC, Weiss R. CRT non-responder rates in patients with atrial fibrillation. Europace 2009

11. Bargas RL, Coogan, E, Lowery CM, Kenny C, Movassaghi B, Wink O, Peterson D, Lewkowiez L, Sauer WH, Salcedo EE, Khoo MSC. Optimal LV lead placement using real-time overlay of 3D Echocardiographic dyssynchrony shell and rotational fluoroscopy improves CRT response and LV remodling. Heart Rhythm 2009

12. Sauer WH, Drexel T, Belardi D, Bargas R, Stees C, Schuller J, Lowery CM, Khoo MSC. QRS shortening after cardiac resynchronization therapy is associated with increased left ventricular ejection fraction in patients with non-ischemic cardiomyopathy. Heart Rhythm 2009

13. Stees CS, Sauer W, Khoo MSC, Bargas R, Bristow M, Lowes B. Electrical remodeling in response to beta-blocker therapy. Heart Rhythm 2009

14. Bargas RL, Lowery CM, Stees C, Khoo MSC, Sauer WH. Atrial refractory stimulation during atypical atrioventricular nodal reentrant tachycardia (AVNRT) as a method to determine optimal slow pathway ablation site. Heart Rhythm 2009

15. Belardi D, Schuller J, Bargas R, Stees C, Lewkowiez L, Khoo M, Lowery CM, Sauer WH. Wolff in Sheep’s Clothing: Unmasking Sudden Death Risk in Catecholamine Sensitive Accessory Pathways. Journal of the American College of Cardiology 2009.

16. Belardi D, Schuller J, Bargas R, Stees C, Lewkowiez L, Khoo M, Lowery CM, Sauer WH. Identification of an Initial Far-Field Component of the Earliest Endocardial Electrogram Predicts Epicardial Origin of Ventricular Tachycardia. Journal of the American College of Cardiology 2009.

17. Belardi D, Sanders J, Schuller J, Bargas R, Stees C, Lewkowiez L, Khoo M, Lowery CM, Sauer WH. Multiple Scar-Related Macroreentrant Atrial Tachycardias are Common in Patients Presenting with Cavo-Tricuspid Isthmus Dependent Atrial Flutter after Prior Cardiac Surgery. Journal of the American College of Cardiology 2009.

18. Schuller J, Sanders JB, Lowery CM, Belardi D, Khoo MS, Sauer WH, Lewkowiez L. Triggers of Atrial Fibrillation are Suppressed in the Setting of General Anesthesia. Circulation 2008;118:S_588.

19. Laird RE, Kenny C, Lowery CM, Peterson D, Sauer WH, Lewkowiez L, Movassaghi B, Salcedo EE, Khoo MSC. A novel approach to coronary sinus lead implantation using 3D echocardiographic dyssynchrony analysis in conjunction with rotational fluoroscopy. Heart Rhythm 2008.

20. Weiss R, Khoo MSC, Malik R, Wish M, Alawwa A, Dinerman J, Hsu K, Waggoner A, Oza AL. Divergence between CRT non-responder rates based on the NYHA class assessment and 6-minute hall distance criteria. Heart Rhythm 2008.
21. Weiss R, Khoo MSC, Mailk R, Wish M, Alawwa A, Waggoner A, Mowrey K, Oza AL, Srivatsa U. Predictors of clinical response to cardiac resynchronization therapy. Heart Rhythm 2008.

22. Henry-Okafor Q, Cowan P, Khoo MSC. Ethnic differences in cardiovascular risk factors in African-American women and Caucasian women with coronary artery disease. Evidence Based Practice 2007.

23. Yang Y, Zhang R, Khoo MS, Hou Y, Yang J, Colbran R, Anderson ME. Calmodulin kinase II inhibition protects against isoproterenol-induced cardiomyocyte death in vivo. Journal of the American College of Cardiology 45 (3): 174A-174A Suppl. A Feb 1 2005.

24. Yang Y, Zhang R, Khoo M, Hou Y, Ni G, Gurevich V, Yang J, Grueter C, Colbran R, Anderson ME. In Vivo Calmodulin Kinase II Inhibition Protects against Isoproterenol- Induced Cardiomyopathy. Circulation 110(17):65 Suppl S Oct 2004.

25. Wu Y, Khoo MSC, Anderson ME. Anti-arrhythmic actions of calmodulin kinase. Journal of Molecular and Cellular Cardiology 37 (1): 331-331 Jul 2004.

26. Khoo MSC, Kannankeril PJ, Zhang R, Dzhura I, Lwin STS, Kupershmidt S, Zhang W, Atkinson JB, Roden, DM, Colbran RJ, Anderson ME. Calmodulin kinase II is required for normal atrioventricular conduction. Heart Rhythm, 1 (1): S157 May 2004.

27. Khoo MSC, Zhang R, Grueter CE, Ni G, Bass MA, Yang J, Mendes LA, Olson EN, Colbran RJ, Anderson ME. Calmodulin Kinase Inhibition Improves Survival in Calcineurin Transgenic Mice. Journal of the American College of Cardiology 43 (5): 6A-6A Suppl. A Mar 3 2004.

28. Khoo MSC, Zhang R, Grueter CE, Ni G, Bass MA, Painter C, Eren M, Yang J, Madu EC, Mendes LA, Vaughan DE, Colbran RJ, Anderson ME. Calmodulin Kinase Activity Links Green Fluorescent Protein Over-Expression to a Cardiomyopathic Phenotype. Journal of the American College of Cardiology 43 (5): 219A-219A Suppl. A Mar 3 2004.

29. Khoo MSC, Zhang R, Grueter CE, Ni G, Painter CA, Eren, M, Price III E, Grueter CE, Yang Y, Madu EC, Vaughan DE, Anderson ME. Calmodulin Kinase Inhibition Improves Cardiac Function After Myocardial Infarction. Journal of the American College of Cardiology 43 (5): 255A-255A Suppl. A Mar 3 2004.

30. Wu YJ, Zhang R, Dzhura I, Khoo MSC, Colbran RJ, Anderson ME. The gain of cardiac excitation-contraction coupling is reduced in mice with genetic calmodulin kinase inhibition. Biophysical Journal 86 (1): 106A-106A Part 2 Suppl. S, Jan 2004.

31. Ni G, Xu XC, Wang Z, Cherry JC, Albornoz F, Khoo MSC, Zhang W, Rottman JN, Anderson ME, Madu EC. Temporal changes in ventricular function assessed echocardiographically in conscious and sedated mice. Journal of the American Society of Echocardiography 16 (11): 1150-1157 Nov 2003.

32. Khoo MSC, Zhang R, Painter CA, Eren, M, Price E, Grueter CE, Yang Y, Ni G, Madu EC, Vaughan DE, Anderson ME. Novel anti-thrombotic and anti-inflammatory effects of calmodulin kinase inhibition after myocardial infarction. Circulation 108 (17): 104-104 485 Suppl. S Oct 28 2003.

33. Khoo MSC, Zhang R, Kuperschmidt S, Atkinson JB, Zhang W, Roden DM, Anderson ME. Atrioventricular nodal cells are from cardiomyocyte lineage and have conduction properties regulated by calmodulin kinase. Keystone Symposium, January 2003.

34. Zhang R, Khoo MSC, Dzhura I, Ni G, Vishnivetskaya TA, Wu Y, Yang J, Madu E, Gurevich VV, Mark E Anderson. Calmodulin kinase is required for b-adrenergic stimulation in myocardium. Circulation 106 (19): 15 Suppl. S Nov 5 2002.

35. Khoo MSC, Zhang R, Zhang W, Atkinson JB, Colbran RJ, Anderson ME. Calmodulin kinase II activity is required for b-adrenergic effects on sino-atrial impulse formation and atrioventricular conduction. NASPE, May 2002.

36. Khoo MSC, Zhang R, Zhang W, Atkinson JB, Colbran RJ, Anderson ME. Calmodulin kinase II activity is required for b-adrenergic effects on sino-atrial impulse formation and atrioventricular conduction. American Society of Clinical Investigation, April 2002.

37. Zhang R, Wu Y, Khoo MSC, Ni G, Madu E, Colbran R, Anderson ME. Reduced sarcoplasmic reticulum calcium content and normal contractile function in mice with cardiac-targeted calmodulin kinase II inhibition. . Biophysical Journal 82 (1): 869 Part 2 Jan 2002.

38. Khoo MSC, Zhang W, Roden DM, Olson EN, Bass M, Colbran R, Anderson ME. Calmodulin and calmodulin kinase inhibition suppress ventricular tachycardia in calcineurin transgenic mice with heart failure. Circulation 104 (17): 916 Suppl. S Oct 23 2001.

39. Zhang R, Khoo MSC, Colbran R, Anderson ME. Isoproterenol induces atrioventricular conduction block in mice with transgenically targeted, cardiac specific calmodulin kinase II inhibition. Circulation 104 (17): 913 Suppl. S Oct 23 2001.

40. Gerstenfeld EP, Khoo M, Martin R, Cook JR, Lancey R, Rofino K, VanderSalm TJ, Mittleman RS. Effectiveness of bi-atrial pacing for reducing atrial fibrillation after coronary artery bypass graft surgery. NASPE 1999.

41. Khoo SC, Duggan C, Donnelly S, Fraser A and Casey EB. Acute lymphoblastic leukemia presenting with back pain. Irish Journal of Medical Science, Volume 166, Suppl 9 October 1997

Thank you for your interest in scheduling an appointment with Dr. Michelle Khoo. Please call 1-505-248-1802 to request an appointment or click the button below.

SCHEDULE AN APPOINTMENT

If you require more immediate attention, please call our office at (505) 248-1802.